JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB97223

Goat Anti-Human IgG Fc (Biotin)

Be the first to review this product! Submit a review

|

(10 Publications)

Goat Anti-Human IgG Fc (Biotin) is a secondary antibody that is suitable for Western blot, IHC, ICC/IF and ELISA.

- Reacts specifically with Human IgG
- Cross reactivity with other immunoglobulins and light chains is less than 0.1%

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

Key facts

Host species

Goat

Target species

Human

Target isotype

IgG

Target specificity

Fc region

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

Biotin

Excitation/Emission
Applications

ICC/IF, IHC-P, ELISA, WB

applications

Clonality

Polyclonal

Isotype

IgG

Specificity

By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgG. Cross reactivity with other immunoglobulins and light chains is less than 0.1%.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000 - 1/200000", "notes":"<p>(Chemiluminescent)</p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000 - 1/200000", "notes":"<p>(Primary)</p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/250 - 1/2500", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/100 - 1/500", "notes":"<p></p>" } } }

Product details

This antibody reacts with the Fc region of Human IgG

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Antiserum was solid phase adsorbed to ensure class specificity. This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Biotin. Biotinylated antibody was demonstrated with avidin/peroxidase when coated on microtiter wells.
Storage buffer
pH: 6.8 - 7.4 Preservative: 0.09% Sodium azide Constituents: PBS, 0.2% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
See full target information IGHG1

Additional targets

IGHG4,IGHG3,IGHG2

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:3551 PubMed40229328

2025

Cord blood IgA/M reveals in utero response to SARS-CoV-2 with fluctuations in relation to circulating variants.

Applications

Unspecified application

Species

Unspecified reactive species

Olivier Pernet,Toinette Frederick,Amila Adili,Jay Hudgins,Patricia Anthony,Gwyndolyn McCaney,Wendy J Mack,Eunice Noriega,Jennifer Lopez,Steven Balog,Manoj Biniwale,Amy Yeh,Allison Bearden,Rangasamy Ramanathan,Andrea Kovacs

Viruses 13: PubMed34834944

2021

Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2.

Applications

Unspecified application

Species

Unspecified reactive species

Marumi Ohno,Michihito Sasaki,Yasuko Orba,Toshiki Sekiya,Md Abdul Masum,Osamu Ichii,Tatsuya Sawamura,Akemi Kakino,Yasuhiko Suzuki,Hiroshi Kida,Hirofumi Sawa,Masashi Shingai

Frontiers in cell and developmental biology 9:633099 PubMed34095108

2021

cAMP Bursts Control T Cell Directionality by Actomyosin Cytoskeleton Remodeling.

Applications

Unspecified application

Species

Unspecified reactive species

Morgane Simao,Fabienne Régnier,Sarah Taheraly,Achille Fraisse,Rachida Tacine,Marie Fraudeau,Adam Benabid,Vincent Feuillet,Mireille Lambert,Jérôme Delon,Clotilde Randriamampita

Scientific reports 11:10064 PubMed33980989

2021

Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing.

Applications

Unspecified application

Species

Unspecified reactive species

Franziska Bachhuber,André Huss,Makbule Senel,Hayrettin Tumani

Endocrinology 162: PubMed33837405

2021

Pituitary Tumors and Immortalized Cell Lines Generated by Cre-Inducible Expression of SV40 T Antigen.

Applications

Unspecified application

Species

Unspecified reactive species

Alexandre Z Daly,Amanda H Mortensen,Hironori Bando,Sally A Camper

Communications biology 2:386 PubMed31646189

2019

Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake.

Applications

Unspecified application

Species

Unspecified reactive species

Song Yi Ko,WonJae Lee,Hilary A Kenny,Long H Dang,Lee M Ellis,Eric Jonasch,Ernst Lengyel,Honami Naora

Health science reports 1:e74 PubMed30623097

2018

Optimized protocol for detection of native, full-length HIV-1 envelope on the surface of transfected cells.

Applications

Unspecified application

Species

Unspecified reactive species

J B Altman,X Liu,V Itri,S Zolla-Pazner,R L R Powell

Nature medicine 23:1086-1094 PubMed28825717

2017

A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.

Applications

Unspecified application

Species

Unspecified reactive species

Sumeet A Khetarpal,Xuemei Zeng,John S Millar,Cecilia Vitali,Amritha Varshini Hanasoge Somasundara,Paolo Zanoni,James A Landro,Nicole Barucci,William J Zavadoski,Zhiyuan Sun,Hans de Haard,Ildikó V Toth,Gina M Peloso,Pradeep Natarajan,Marina Cuchel,Sissel Lund-Katz,Michael C Phillips,Alan R Tall,Sekar Kathiresan,Paul DaSilva-Jardine,Nathan A Yates,Daniel J Rader

PloS one 11:e0160068 PubMed27685990

2016

Cocaine-and Amphetamine Regulated Transcript (CART) Peptide Is Expressed in Precursor Cells and Somatotropes of the Mouse Pituitary Gland.

Applications

Unspecified application

Species

Unspecified reactive species

Amanda H Mortensen,Sally A Camper

Human molecular genetics 24:939-53 PubMed25315894

2014

Deletion of OTX2 in neural ectoderm delays anterior pituitary development.

Applications

Unspecified application

Species

Unspecified reactive species

Amanda H Mortensen,Vanessa Schade,Thomas Lamonerie,Sally A Camper
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com